Scott T. Rottinghaus, Senior VP & CMO at ENANTA PHARMACEUTICALS INC (ENTA), sold 534 shares at $9.63 ($5K) on 2023-12-05, disclosed to the SEC on 2023-12-06.
Open-market sale of $5k ENTA by Senior VP & CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ENTA | SELL | 2024-07-15 | $347K | — | Filing → |